Fig. 4.
Overall survival in relation baseline alkaline phosphatase (ALPBL) status (normal in 16 patients, elevated in 40; one patient did not have any baseline data). Median survival times: 401 days in patients with normal ALPBL, and 222 days in those with elevated ALPBL. Median follow-up times: 468 days in patients with normal ALPBL, and 234 days in those with elevated ALPBL. ,. *p = 0.01 vs. normal ALPBL